Tag Archive for: Neisserai

LimmaTech Biologics is based in the Bio-Technopark Schlieren-Zurich. © Limmatstadt AG

Swiss multivalent vaccine developer LimmaTech Biologics AG has been awarded US$2.2m rom the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).